Travel-associated sexually transmitted infections among HIV and non-HIV infected travelers.
The incidence of sexually transmitted infections (STI) is increasing in Western countries while travel plays a major role in STI dissemination worldwide. However, there is no study distinguishing HIV-positive and HIV-negative travelers. We retrospectively evaluated the epidemiological, clinical and biological characteristics of the patients diagnosed with a travel-related STI between 2008 and 2016. We describe and compare the spectrum of STI diagnosed among HIV-positive and negative travelers. Overall, 163 travel-related STI were identified in 140 patients (89% Male, 54% men having sex with men, 40% HIV-positive). Symptoms occurred during travel in 39% of them, otherwise the median time between return and symptoms' onset was 13 days. Among the 84 HIV-negative travelers, the main STI were primary HIV infections (n=36, 38%), Neisseria gonorrhoeae (NG) infections (17%) and primary herpes infection (14%, vs 1.5% among HIV-positive travelers, p=0.01). The regions of exposure to HIV were concordant with the known geographical distribution of HIV subtypes. Among the 56 HIV-positive travelers, the main STI were syphilis (43%, vs 6% among HIV-negative travelers, p=0.01), Chlamydia trachomatis (CT) infections (22%, vs 13% among HIV-negative travelers, p=0.08), NG infections (13%) and acute hepatitis C (12%, vs 1% among HIV-negative travelers, p=0.01), with a predominance of anal forms for both CT and NG infections. The spectrum of STI diagnosed in returning travelers is broad with important differences according to HIV status. In our setting, primary HIV infection was the leading STI in non-HIV infected patients, which suggests that pre-exposure prophylaxis may have a role in HIV prevention in at-risk travelers.